<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>03573026624750</udiDi>
    <basicUdiDi>357302BUDI000834U3</basicUdiDi>
    <tradeName>ETEST® ESBL Cefepime/cefepime + clavulanic acid (PM/PML)</tradeName>
    <deviceName>ETEST® ESBL Cefepime/cefepime + clavulanic acid (PM/PML)</deviceName>
    <manufacturerName>bioMérieux SA</manufacturerName>
    <manufacturerSrn>FR-MF-000004436</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf B</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0104080505</emdnCode>
    <emdnDescription>TARGETED RESISTANCE TESTS - ESBL</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>543022</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-30T18:00:01.127Z</lastUpdated>
  </row>
  <row>
    <udiDi>03573026624736</udiDi>
    <basicUdiDi>357302BUDI000826U4</basicUdiDi>
    <tradeName>ETEST® ESBL Cefotaxime/cefotaxime + clavulanic acid (CT/CTL)</tradeName>
    <deviceName>ETEST® ESBL Cefotaxime/cefotaxime + clavulanic acid (CT/CTL)</deviceName>
    <manufacturerName>bioMérieux SA</manufacturerName>
    <manufacturerSrn>FR-MF-000004436</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf B</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0104080505</emdnCode>
    <emdnDescription>TARGETED RESISTANCE TESTS - ESBL</emdnDescription>
    <deviceStatus>AB pazarı için değil</deviceStatus>
    <reference>543020</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-30T17:59:58.710Z</lastUpdated>
  </row>
  <row>
    <udiDi>03573026624712</udiDi>
    <basicUdiDi>357302BUDI000828U8</basicUdiDi>
    <tradeName>ETEST® ESBL Ceftazidime/ceftazidime + clavulanic acid (TZ/TZL)</tradeName>
    <deviceName>ETEST® ESBL Ceftazidime/ceftazidime + clavulanic acid (TZ/TZL)</deviceName>
    <manufacturerName>bioMérieux SA</manufacturerName>
    <manufacturerSrn>FR-MF-000004436</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf B</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0104080505</emdnCode>
    <emdnDescription>TARGETED RESISTANCE TESTS - ESBL</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>542962</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-30T17:59:57.125Z</lastUpdated>
  </row>
  <row>
    <udiDi>03573026624019</udiDi>
    <basicUdiDi>357302BUDI002013SZ</basicUdiDi>
    <tradeName>ETEST® Imipenem/Relebactam (IPR)</tradeName>
    <deviceName>ETEST® Imipenem/Relebactam (IPR)</deviceName>
    <manufacturerName>bioMérieux SA</manufacturerName>
    <manufacturerSrn>FR-MF-000004436</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf B</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0104080501</emdnCode>
    <emdnDescription>MIC SYSTEMS - DILUTION METHODS (INCL. E-TEST)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>542988</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-30T17:59:54.726Z</lastUpdated>
  </row>
  <row>
    <udiDi>03573026623944</udiDi>
    <basicUdiDi>357302BUDI000771U4</basicUdiDi>
    <tradeName>ETEST® Cefixime (IX)</tradeName>
    <deviceName>ETEST® Cefixime (IX)</deviceName>
    <manufacturerName>bioMérieux SA</manufacturerName>
    <manufacturerSrn>FR-MF-000004436</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf B</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0104080501</emdnCode>
    <emdnDescription>MIC SYSTEMS - DILUTION METHODS (INCL. E-TEST)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>542981</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-30T17:59:52.314Z</lastUpdated>
  </row>
  <row>
    <udiDi>03573026623999</udiDi>
    <basicUdiDi>357302BUDI002036TD</basicUdiDi>
    <tradeName>ETEST® Meropenem/Vaborbactam (MEV)</tradeName>
    <deviceName>ETEST® Meropenem/Vaborbactam (MEV)</deviceName>
    <manufacturerName>bioMérieux SA</manufacturerName>
    <manufacturerSrn>FR-MF-000004436</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf B</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0104080501</emdnCode>
    <emdnDescription>MIC SYSTEMS - DILUTION METHODS (INCL. E-TEST)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>542986</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-30T17:59:49.903Z</lastUpdated>
  </row>
  <row>
    <udiDi>03573026623968</udiDi>
    <basicUdiDi>357302BUDI000792UC</basicUdiDi>
    <tradeName>ETEST® Moxifloxacin (MX)</tradeName>
    <deviceName>ETEST® Moxifloxacin (MX)</deviceName>
    <manufacturerName>bioMérieux SA</manufacturerName>
    <manufacturerSrn>FR-MF-000004436</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf B</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0104080501</emdnCode>
    <emdnDescription>MIC SYSTEMS - DILUTION METHODS (INCL. E-TEST)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>542983</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-30T17:59:49.184Z</lastUpdated>
  </row>
  <row>
    <udiDi>03573026623845</udiDi>
    <basicUdiDi>357302BUDI000766UB</basicUdiDi>
    <tradeName>ETEST® Aztreonam (AT)</tradeName>
    <deviceName>ETEST® Aztreonam (AT)</deviceName>
    <manufacturerName>bioMérieux SA</manufacturerName>
    <manufacturerSrn>FR-MF-000004436</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf B</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0104080501</emdnCode>
    <emdnDescription>MIC SYSTEMS - DILUTION METHODS (INCL. E-TEST)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>542971</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-30T17:59:33.026Z</lastUpdated>
  </row>
  <row>
    <udiDi>03573026623807</udiDi>
    <basicUdiDi>357302BUDI000802TN</basicUdiDi>
    <tradeName>ETEST® Trimethoprim/sulfamethoxazole (1/19) (TS)</tradeName>
    <deviceName>ETEST® Trimethoprim/sulfamethoxazole (1/19) (TS)</deviceName>
    <manufacturerName>bioMérieux SA</manufacturerName>
    <manufacturerSrn>FR-MF-000004436</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf B</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0104080501</emdnCode>
    <emdnDescription>MIC SYSTEMS - DILUTION METHODS (INCL. E-TEST)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>542967</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-30T17:59:31.422Z</lastUpdated>
  </row>
  <row>
    <udiDi>03573026623784</udiDi>
    <basicUdiDi>357302BUDI000788UM</basicUdiDi>
    <tradeName>ETEST® Levofloxacin (LE)</tradeName>
    <deviceName>ETEST® Levofloxacin (LE)</deviceName>
    <manufacturerName>bioMérieux SA</manufacturerName>
    <manufacturerSrn>FR-MF-000004436</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf B</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0104080501</emdnCode>
    <emdnDescription>MIC SYSTEMS - DILUTION METHODS (INCL. E-TEST)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>542965</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-30T17:59:30.626Z</lastUpdated>
  </row>
  <row>
    <udiDi>03573026622374</udiDi>
    <basicUdiDi>357302BUDI000804TS</basicUdiDi>
    <tradeName>ETEST® Vancomycin (VA)</tradeName>
    <deviceName>ETEST® Vancomycin (VA)</deviceName>
    <manufacturerName>bioMérieux SA</manufacturerName>
    <manufacturerSrn>FR-MF-000004436</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf B</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0104080501</emdnCode>
    <emdnDescription>MIC SYSTEMS - DILUTION METHODS (INCL. E-TEST)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>542900</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-30T17:59:25.024Z</lastUpdated>
  </row>
  <row>
    <udiDi>03573026622350</udiDi>
    <basicUdiDi>357302BUDI000800TJ</basicUdiDi>
    <tradeName>ETEST® Tigecycline (TGC)</tradeName>
    <deviceName>ETEST® Tigecycline (TGC)</deviceName>
    <manufacturerName>bioMérieux SA</manufacturerName>
    <manufacturerSrn>FR-MF-000004436</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf B</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0104080501</emdnCode>
    <emdnDescription>MIC SYSTEMS - DILUTION METHODS (INCL. E-TEST)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>542898</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-30T17:59:24.227Z</lastUpdated>
  </row>
  <row>
    <udiDi>03573026622343</udiDi>
    <basicUdiDi>357302BUDI000799US</basicUdiDi>
    <tradeName>ETEST® Tetracycline (TC)</tradeName>
    <deviceName>ETEST® Tetracycline (TC)</deviceName>
    <manufacturerName>bioMérieux SA</manufacturerName>
    <manufacturerSrn>FR-MF-000004436</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf B</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0104080501</emdnCode>
    <emdnDescription>MIC SYSTEMS - DILUTION METHODS (INCL. E-TEST)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>542897</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-30T17:59:19.456Z</lastUpdated>
  </row>
  <row>
    <udiDi>03573026622336</udiDi>
    <basicUdiDi>357302BUDI000808U2</basicUdiDi>
    <tradeName>ETEST® Piperacillin/Tazobactam (P/T)</tradeName>
    <deviceName>ETEST® Piperacillin/Tazobactam (P/T)</deviceName>
    <manufacturerName>bioMérieux SA</manufacturerName>
    <manufacturerSrn>FR-MF-000004436</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf B</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0104080501</emdnCode>
    <emdnDescription>MIC SYSTEMS - DILUTION METHODS (INCL. E-TEST)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>542896</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-30T17:59:18.625Z</lastUpdated>
  </row>
  <row>
    <udiDi>03573026622329</udiDi>
    <basicUdiDi>357302BUDI000791UA</basicUdiDi>
    <tradeName>ETEST® Metronidazole (MZH)</tradeName>
    <deviceName>ETEST® Metronidazole (MZH)</deviceName>
    <manufacturerName>bioMérieux SA</manufacturerName>
    <manufacturerSrn>FR-MF-000004436</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf B</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0104080501</emdnCode>
    <emdnDescription>MIC SYSTEMS - DILUTION METHODS (INCL. E-TEST)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>542895</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-30T17:59:17.832Z</lastUpdated>
  </row>
  <row>
    <udiDi>03573026622312</udiDi>
    <basicUdiDi>357302BUDI000790U8</basicUdiDi>
    <tradeName>ETEST® Meropenem (MP)</tradeName>
    <deviceName>ETEST® Meropenem (MP)</deviceName>
    <manufacturerName>bioMérieux SA</manufacturerName>
    <manufacturerSrn>FR-MF-000004436</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf B</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0104080501</emdnCode>
    <emdnDescription>MIC SYSTEMS - DILUTION METHODS (INCL. E-TEST)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>542894</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-30T17:59:17.020Z</lastUpdated>
  </row>
  <row>
    <udiDi>03573026622305</udiDi>
    <basicUdiDi>357302BUDI000789UP</basicUdiDi>
    <tradeName>ETEST® Linezolid (LZ)</tradeName>
    <deviceName>ETEST® Linezolid (LZ)</deviceName>
    <manufacturerName>bioMérieux SA</manufacturerName>
    <manufacturerSrn>FR-MF-000004436</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf B</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0104080501</emdnCode>
    <emdnDescription>MIC SYSTEMS - DILUTION METHODS (INCL. E-TEST)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>542893</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-30T17:59:13.019Z</lastUpdated>
  </row>
  <row>
    <udiDi>03573026622299</udiDi>
    <basicUdiDi>357302BUDI000786UH</basicUdiDi>
    <tradeName>ETEST® Imipenem (IP)</tradeName>
    <deviceName>ETEST® Imipenem (IP)</deviceName>
    <manufacturerName>bioMérieux SA</manufacturerName>
    <manufacturerSrn>FR-MF-000004436</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf B</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0104080501</emdnCode>
    <emdnDescription>MIC SYSTEMS - DILUTION METHODS (INCL. E-TEST)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>542892</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-30T17:59:12.219Z</lastUpdated>
  </row>
  <row>
    <udiDi>03573026622282</udiDi>
    <basicUdiDi>357302BUDI000785UF</basicUdiDi>
    <tradeName>ETEST® Gentamicin (GM)</tradeName>
    <deviceName>ETEST® Gentamicin (GM)</deviceName>
    <manufacturerName>bioMérieux SA</manufacturerName>
    <manufacturerSrn>FR-MF-000004436</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf B</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0104080501</emdnCode>
    <emdnDescription>MIC SYSTEMS - DILUTION METHODS (INCL. E-TEST)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>542891</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-30T17:59:11.435Z</lastUpdated>
  </row>
  <row>
    <udiDi>03573026622275</udiDi>
    <basicUdiDi>357302BUDI002017T9</basicUdiDi>
    <tradeName>ETEST® Fosfomycin (FO)</tradeName>
    <deviceName>ETEST® Fosfomycin (FO)</deviceName>
    <manufacturerName>bioMérieux SA</manufacturerName>
    <manufacturerSrn>FR-MF-000004436</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf B</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0104080501</emdnCode>
    <emdnDescription>MIC SYSTEMS - DILUTION METHODS (INCL. E-TEST)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>542890</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-30T17:59:10.618Z</lastUpdated>
  </row>
</eudamedExport>